1. Keizo Asami Immunopathology Laboratory, Federal University of Pernambuco, Recife, Brazil;
2. Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil;
3. Department of Genetics, Federal University of Pernambuco, Recife, Brazil;
4. Department of Biomedicine, University of Basel, Basel, Switzerland;
5. Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil;
6. Hematology Department, AC Camargo Cancer Center, São Paulo, Brazil;
7. Department of Internal Medicine, Medical School of Ribeirão Preto, Ribeirão Preto, Brazil;
8. Department of Hematology, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, United Kingdom;
9. Medical Research Council (MRC) Molecular Hematology Unit, Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom;
10. Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil;
11. Hematology and Transfusion Medicine Center and
12. Department of Internal Medicine, University of Campinas, Campinas, São Paulo, Brazil; and
13. Department of Biochemistry, Federal University of Pernambuco, Recife, Brazil